retatrutide triple hormone receptor agonist metabolic growth interaction for dysfunction-associated steatotic liver disease: a randomized phase 2a trial The future of metabolic science – retatrutide triple agonist glp-1 gip

Usage Instructions Scoop cream with fingers from container

This can increase your chances of side effects like stomach irritation and potential liver damage

Rekha Kumar, MS, MD, endocrinologist, obesity medicine specialist and senior medical advisor at Found, describes Eli Lilly's retatrutide (nicknamed "reta") as a "next-generation" weight-loss medication that is still awaiting FDA approval, but currently in late-stage clinical trials

According to NICE guidance (NG28) , GLP-1 receptor agonists may be considered as part of treatment regimens when other glucose-lowering treatments have not achieved adequate control